New non-executive director joins our board

Friday, 10 February 2017

Professor John Iredale has joined the board of North Bristol NHS Trust as a non-executive directorWe have welcomed a new non-executive director to our board.

Professor John Iredale, Pro Vice Chancellor (Health) at the University of Bristol, brings experience as a non-executive director with one of the largest health organisations in the UK, having been on the board of NHS Lothian from 2010 – 2016. During his time at the health board he played a lead role in aligning university and NHS activities.

Professor Iredale holds the chair of Experimental Medicine at the university, with responsibility for the research, teaching and management strategy for the Schools of Medicine, Veterinary Medicine, Dentistry and Biomedical Sciences across the relevant Faculties.

He also holds honorary consultant contracts with North Bristol NHS Trust and University Hospitals Bristol NHS Foundation Trust.

Professor Iredale was previously the Regius Chair of Medical Science, Dean of Clinical Medicine and Vice Principal Health Services at the University of Edinburgh where he led the Medical School.

He has held the Chair of Medicine in Edinburgh (2006-2013), the chair of Medicine at the University of Southampton (2004-2006) and a Personal Chair in Hepatology (2000-2004).

Professor Iredale said: “With my background in health and research I am looking forward to helping guide North Bristol NHS Trust to achieve its ambitions to lead state of the art healthcare and deliver the research necessary to drive new treatments and improvements in outcomes and the quality of care for our NHS patients.

“Having been a Non Executive Director of NHS Lothian, one of the UK’s largest health boards, I hope to bring  appropriate experience and intend to help strengthen links between the Trust and the university further, as I did at NHS Lothian.”

Welcoming, Professor Iredale to the board, Chairman Peter Rilett said: “We are delighted to have John on the board. He brings a wealth of experience that will help in driving us towards our objectives of being a leader in research and establishing new ways of providing healthcare services to our community.”